These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

430 related items for PubMed ID: 26805419

  • 1. Skin compatibility and efficacy of a cosmetic skin care regimen with licochalcone A and 4-t-butylcyclohexanol in patients with rosacea subtype I.
    Schoelermann AM, Weber TM, Arrowitz C, Rizer RL, Qian K, Babcock M.
    J Eur Acad Dermatol Venereol; 2016 Feb; 30 Suppl 1():21-7. PubMed ID: 26805419
    [Abstract] [Full Text] [Related]

  • 2. Skin tolerance, efficacy, and quality of life of patients with red facial skin using a skin care regimen containing Licochalcone A.
    Weber TM, Ceilley RI, Buerger A, Kolbe L, Trookman NS, Rizer RL, Schoelermann A.
    J Cosmet Dermatol; 2006 Sep; 5(3):227-32. PubMed ID: 17177744
    [Abstract] [Full Text] [Related]

  • 3. Efficacy and Tolerability of a Cosmetic Skin Care Product With Trans-4-t-butylcyclohexanol and Licochalcone A in Subjects With Sensitive Skin Prone to Redness and Rosacea.
    Jovanovic Z, Angabini N, Ehlen S, Mokos ZB, Subotic M, Neufang G.
    J Drugs Dermatol; 2017 Jun 01; 16(6):605-610. PubMed ID: 28686779
    [Abstract] [Full Text] [Related]

  • 4. Effective treatment for sensitive skin: 4-t-butylcyclohexanol and licochalcone A.
    Sulzberger M, Worthmann AC, Holtzmann U, Buck B, Jung KA, Schoelermann AM, Rippke F, Stäb F, Wenck H, Neufang G, Grönniger E.
    J Eur Acad Dermatol Venereol; 2016 Feb 01; 30 Suppl 1():9-17. PubMed ID: 26805417
    [Abstract] [Full Text] [Related]

  • 5. Randomized investigator-blinded comparative study of moisturizer containing 4-t-butylcyclohexanol and licochalcone A versus 0.02% triamcinolone acetonide cream in facial dermatitis.
    Boonchai W, Varothai S, Winayanuwattikun W, Phaitoonvatanakij S, Chaweekulrat P, Kasemsarn P.
    J Cosmet Dermatol; 2018 Dec 01; 17(6):1130-1135. PubMed ID: 29411520
    [Abstract] [Full Text] [Related]

  • 6. Natural Skin Care Products as Adjunctive to Prescription Therapy in Moderate to Severe Rosacea.
    Draelos ZD, Gunt H, Levy SB.
    J Drugs Dermatol; 2019 Feb 01; 18(2):141-146. PubMed ID: 30794364
    [Abstract] [Full Text] [Related]

  • 7. A Cosmetic Regimen Formulated to Address the Multi-Modal Pathogenesis of Rosacea Demonstrates Efficacy for Treating Facial Redness and Skin's Appearance.
    Farris PK, Gerstein FH, Baldwin HE, Draelos ZD.
    J Drugs Dermatol; 2024 Sep 01; 23(9):757-763. PubMed ID: 39231085
    [Abstract] [Full Text] [Related]

  • 8. Open-label study assessing the efficacy and tolerability of topical skin care and sun protection alone and in combination with intense pulsed light therapy.
    Deaver Peterson J, Katz TM.
    J Cosmet Dermatol; 2019 Dec 01; 18(6):1758-1764. PubMed ID: 31017734
    [Abstract] [Full Text] [Related]

  • 9. A novel moisturizer with high sun protection factor improves cutaneous barrier function and the visible appearance of rosacea-prone skin.
    Baldwin H, Santoro F, Lachmann N, Teissedre S.
    J Cosmet Dermatol; 2019 Dec 01; 18(6):1686-1692. PubMed ID: 30803131
    [Abstract] [Full Text] [Related]

  • 10. The appearance of facial foundation cosmetics applied after metronidazole gel 1%.
    Draelos ZD, Colón LE, Preston N, Johnson LA, Gottschalk RW.
    Cutis; 2011 May 01; 87(5):251-9. PubMed ID: 21699130
    [Abstract] [Full Text] [Related]

  • 11. Efficacy of a skin care cream with TRPV1 inhibitor 4-t-butylcyclohexanol in the topical therapy of perioral dermatitis.
    Srour J, Bengel J, Linden T, Jovanovic Z, Roggenkamp D, Reinholz M, Rothenberger C, Neufang G, Wollenberg A.
    J Cosmet Dermatol; 2020 Jun 01; 19(6):1409-1414. PubMed ID: 31660683
    [Abstract] [Full Text] [Related]

  • 12. Efficacy and safety of oxymetazoline cream 1.0% for treatment of persistent facial erythema associated with rosacea: Findings from the 52-week open label REVEAL trial.
    Draelos ZD, Gold MH, Weiss RA, Baumann L, Grekin SK, Robinson DM, Kempers SE, Alvandi N, Weng E, Berk DR, Ahluwalia G.
    J Am Acad Dermatol; 2018 Jun 01; 78(6):1156-1163. PubMed ID: 29409914
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pivotal Trial of the Efficacy and Safety of Oxymetazoline Cream 1.0% for the Treatment of Persistent Facial Erythema Associated With Rosacea: Findings from the Second REVEAL Trial.
    Baumann L, Goldberg DJ, Stein Gold L, Tanghetti EA, Lain E, Kaufman J, Weng E, Berk DR, Ahluwalia G.
    J Drugs Dermatol; 2018 Mar 01; 17(3):290-298. PubMed ID: 29537447
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Comparison of skin calming effects of cosmetic products containing 4-t-butylcyclohexanol or acetyl dipeptide-1 cetyl ester on capsaicin-induced facial stinging in volunteers with sensitive skin.
    Schoelermann AM, Jung KA, Buck B, Grönniger E, Conzelmann S.
    J Eur Acad Dermatol Venereol; 2016 Feb 01; 30 Suppl 1():18-20. PubMed ID: 26805418
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.